SCHEMBL22422492

SCHEMBL22422492

C=CC1C(O[C@@H](COC(=O)c2c(O)cc(O)cc2-c2cccc(O)c2)OC(CO)CCO)OC=C2C(=O)CCCC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12251277 0.77 — —
SCHEMBL13998188 0.73 STAT3 (0.43) —
SCHEMBL22662483 0.66 STAT3 (0.61) —
SCHEMBL22662484 0.66 STAT3 (0.61) —
SCHEMBL1031187 0.66 STAT3 (0.61) —
SCHEMBL29655170 0.60 STAT3 (0.61) —
SCHEMBL22645247 0.57 STAT3 (0.59) —
SCHEMBL22699377 0.52 NR1H2 (0.66) —
SCHEMBL8707573 0.52 SMN1; SMN2 (0.38) —
SCHEMBL8707576 0.50 ESR1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2661266-B1 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ANJI PHARMA (US) LLC (US) 2020-09-16 — — EP disclosed
Send feedback